Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
4,267
Views
29
CrossRef citations to date
0
Altmetric
Review

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer

Qian Tanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, ChinaView further author information
,
Hu Ouyanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, ChinaView further author information
,
Dongxiu Hea Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaCorrespondence[email protected]
View further author information
,
Cuiyun Yua Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaView further author information
&
Guotao Tanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaView further author information
Pages 2800-2809 | Received 03 Apr 2019, Accepted 24 Jun 2019, Published online: 09 Jul 2019
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by high recurrence rates and poor prognosis compared to other breast cancers. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of various post-transcriptional gene and silence a broad set of target genes. Many recent studies have demonstrated that miRNAs play an important role in the initiation, promotion, malignant conversion, progression, and metastasis of TNBC. Therefore, the aim of this review is to focus on recent advancements of microRNAs-based potential applications in diagnosis, treatment and prognosis of triple-negative breast cancer.

Acknowledgement

Financial assistance received from Innovation platform Open Foundation of education department of Hunan province is acknowledged with thanks.

Disclosure statement

The authors declare that they have no conflict of interest.

Additional information

Funding

This work was supported by Innovation platform Open Foundation of education department of Hunan province [contract grant number 16K079, 17K082] and University of South China Innovation Foundation For Postgraduate.

Related Research Data

MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)
Source: Elsevier BV
Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients
Source: Springer Science and Business Media LLC
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Source: Springer Science and Business Media LLC
Triple negative breast cancer: unmet medical needs.
Source: Springer Science and Business Media LLC
WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade.
Source: Wiley
miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
Source: Public Library of Science (PLoS)
MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
Source: Public Library of Science (PLoS)
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
Source: Impact Journals, LLC
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
Source: Informa UK Limited
Breast Cancer Statistics, 2013
Source: Wiley
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Source: Oxford University Press (OUP)
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
Source: American Society for Biochemistry & Molecular Biology (ASBMB)
A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple Negative Breast Cancer Patients
Source: American Association for Cancer Research (AACR)
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
Source: Springer Nature
microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells.
Source: Spandidos Publications
miR-542-3p in neuroblastoma
Source: Wiley
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Source: American Chemical Society (ACS)
MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells.
Source: Elsevier BV
MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
Source: Elsevier BV
miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.
Source: Elsevier BV
Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
Source: American Society for Investigative Pathology. Published by Elsevier Inc.
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Source: American Association for Cancer Research (AACR)
Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Source: Elsevier BV
MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.
Source: Springer Science and Business Media LLC
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth
Source: Springer Science and Business Media LLC
Triple-negative breast cancer: new perspectives for targeted therapies.
Source: Informa UK Limited
Erratum: miR-520h is crucial for DAPK2 regulation and breast cancer progression
Source: Springer Science and Business Media LLC
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Source: American Association for Cancer Research (AACR)
MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.
Source: Ivyspring International Publisher
miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Source: Springer Science and Business Media LLC
A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
Source: Public Library of Science (PLoS)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Source: Springer Nature
Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway
Source: Elsevier BV
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
Source: Springer Science and Business Media LLC
Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer
Source: Springer Science and Business Media LLC
miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
Source: Public Library of Science (PLoS)
Differential Expression of MicroRNAs in Different Disease States
Source: Ovid Technologies (Wolters Kluwer Health)
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
Source: Springer Science and Business Media LLC
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.
Source: American Association for Cancer Research (AACR)
miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1
Source: American Association for Cancer Research (AACR)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Source: Springer Science and Business Media LLC
Suppression of cell growth and invasion by miR-205 in breast cancer
Source: Springer Science and Business Media LLC
miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4.
Source: Elsevier BV
miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
Source: Springer Nature
miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
Source: Spandidos Publications
miR-34a modulates ErbB2 in breast cancer
Source: Wiley
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Source: Springer Science and Business Media LLC

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.